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Background/Aims: Ardabil Province, in northwestern Iran, has the highest rate of gastric (predominantly
cardia) adenocarcinoma in Iran. This study aimed to investigate the feasibility of endoscopic screening and
to look for associated Helicobacter pylori infection and gastric precancerous lesions.
Methods: One thousand one hundred and five adult volunteers, residents of Ardabil and Meshkinshahr,
districts, 40 years old and above were selected and invited by a simple random household canvass in rural
and urban locations. Informed consents were obtained and upper gastrointestinal video endoscopy was
performed to biopsy all visible lesions and standard sites in the antrum, corpus, and cardia
Results: One thousand and eleven of the invited individuals agreed to participate, including 494 men and
517 women, with a mean (SD) age of 53.32 (10.39) years. Endoscopy was well tolerated by all subjects;
96.7% of antral and 80.7% of cardia mucosal biopsies were satisfactory. The urease test or histology for
H pylori was positive in at least 89.2% of subjects. Histological evidence of mucosal atrophy was seen in
39.3% of antral and 21.9% of cardia samples. Chronic gastritis with or without activity, reactive atypia of
glandular epithelium, intestinal metaplasia, dysplasia, and cancer were found in 95.1%, 38.0%, 8.7%,
0.2%, and 0.3% of antral and 85.3%, 22.9%, 3.8%, 0.3%, and 0.1% of cardiac biopsies, respectively.
Conclusion: Endoscopic screening for upper gastrointestinal diseases was feasible and well tolerated in
Ardabil, Iran. Most subjects showed H pylori infection. Atrophic gastritis, reactive atypia, and intestinal
metaplasia were common in antrum, corpus, and cardia subsites.
G
astric adenocarcinoma is the second most common
cause of cancer related mortality in the world.1 2 This
tumour is also the most common gastrointestinal (GI)
malignancy in Iran.3 4 Ardabil, a northwestern province of
Iran, was reported to have the highest incidence of gastric
adenocarcinoma in the whole country. According to an active
cancer surveillance programme in Ardabil Province, covering
a period of four years (1996–1999), this lesion constitutes
31% of all malignancies seen in that region, with an incidence
rate of 49.1 and 25.4/100 000/year for men and women,
respectively.5 A prospective study of patients with upper GI
malignancy diagnosed in a single referral centre in the city of
Ardabil during a period of one year revealed that the
proximal stomach (cardia) is the most common location for
malignancy in the upper GI, constituting about 50% of the
cases in that series.6 Helicobacter pylori is known to be involved
in the multistep process that finally leads to gastric
adenocarcinoma, with estimates of attributable risk up to
75%.7 8
‘‘Eradication of Helicobacter pylori infection is a promis-
ing option for the prevention of gastric cancer, at least in
high risk regions of the world’’
This organism has been classified as a member of the group
1 carcinogenic agents by the World Health Organisation.9 A
recent study using an animal model has clearly shown that
long term H pylori infection of the gastric mucosa can
progress to adenocarcinoma.10 Uemura et al showed that both
intestinal and diffuse type gastric adenocarcinoma were
closely associated with H pylori infection.11 This evidence,
together with the very low five year survival rate of gastric
cancer, favours the notion that eradication of H pylori
infection is a promising option for the prevention of gastric
cancer, at least in high risk regions of the world. There is also
some evidence to support the protective effects of antioxi-
dants, such as b carotene and ascorbic acid, against gastric
cancer,12 and the results of a recently published randomised
controlled trail revealed that H pylori eradication, together
with supplementing the diet with antioxidants as a pre-
ventive strategy has considerable public health potential.13
During a scientific collaboration between the Digestive
Disease Research Centre (DDRC) of Tehran University of
Medical Sciences and Ardabil University of Medical Sciences,
aimed at devising a preventive strategy for gastric cancer in
Ardabil, we sought to investigate the feasibility of endoscopic
screening studies and to monitor the prevalence of H pylori
infection and its related precancerous lesions in the residents
of two major districts of the Ardabil Province.
MATERIALS AND METHODS
Study population
Our study was performed between June and September 2000
in Ardabil district, which has a total population of 435 487,
and July and September 2001 in Meshkinshahr district,
which has a population of 164 007. In total, 1105 households
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Abbreviations: DDRC, Digestive Disease Research Centre; GI,
gastrointestinal; IM, intestinal metaplasia
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were canvassed in both districts. Part of each city was
selected on a random basis, incorporating the adjoining rural
area lying within a distance of 5–50 km from the city limits,
an area that included 17 villages in Ardabil and 19 villages in
Meshkinshahr. Expert local health professionals interviewed
those members of the family who were aged 40 years or
more, and thoroughly explained the purpose and procedure
of the study to them. One individual from the target age
group in each family was randomly selected to be invited to
participate in our study. If such an individual was not
available, or was excluded by any of the exclusion criteria, the
immediate neighbour to the right hand side was referred to
for the same process. Exclusion criteria used in our study
were: unwillingness to participate at any stage of the study
and for any reason, inability to tolerate upper GI endoscopy
for any reason decided by the health professional during the
interview or the gastroenterologist in charge at the time of
endoscopy, history of known gastrointestinal disease in the
past, or the presence of significant benign or malignant upper
GI disease. All the individuals who were willing to participate
were transferred to the site of study on the appointed day.
PROCEDURES
Upon arrival at the endoscopy clinic on the appointed day,
the purpose of our study and the risks and benefits of the
procedures were explained to the participants for the second
time and the individuals signed a written informed consent
to undergo the procedures necessary for our study. The study
protocol and the informed consent used for this investigation
were approved by the ethics committee of the DDRC, Tehran
University of Medical Sciences before the study.
Before endoscopy, each participant was interviewed by a
trained interviewer (general practitioner) to obtain the
necessary information by filling in a questionnaire. The
questionnaire was designed to collect demographic, nutri-
tional, and important life style information. Specific sections
included questions covering the staple diet and nutritional
variety, food preservation facilities, and source of drinking
water. Other sections included questions about life style and
habits including smoking, alcohol, and drug abuse. Pertinent
history for any important health problem with emphasis on
important GI symptoms was obtained. The individuals were
asked about any history of upper GI malignancy in first
degree relatives.
After the interview, a limited physical examination was
performed including the recording of height and weight. A
few drops of blood taken from the tip of a finger punctured
by a lancet under disinfected conditions were collected on to
a Watman No. 1 filter paper to be used as a source of DNA for
possible future molecular studies. Nails were clipped from the
fingers and toes and about 0.5 g of the individual’s hair was
cut for future assessment of trace elements and toxicological
studies deemed important in gastric carcinogenesis.
The participants then underwent standard upper GI video
endoscopy under sedation with Midazolam (5–7.5 mg slow
intravenous push) under monitoring and local anaesthesia of
pharyngeal mucosa with 10% Lidocaine spray. A list of the
endoscopic findings, using a special coding system for
different lesions and a special endoscopy report form, were
used to record the visual findings and generate an endoscopy
report for future clinical decisions for the participant if
necessary. The gastroenterologists in charge of the endoscopy
procedure were assisted by trained personnel and general
practitioners during the endoscopy and documentation of the
endoscopic findings. Images of all the abnormal findings in
the oesophagus, stomach, and duodenum were captured.
Gastric biopsies were taken from the following sites:
N Incisura angularis for rapid urease test (first biopsy).
N Antrum, two biopsies, one between the incisura angularis
and pyloric canal and the other on the opposite side over
the greater curvature.
N Cardia, two biopsies 0.5 to 1.0 cm below the gastro–
oesophageal junction on the anterior and posterior gastric
wall.
N All the visible lesions (number of biopsies and sites
decided according to the endoscopic features noted by the
gastroenterologist).
In addition to the above biopsies, two more biopsies from
the corpus at greater and lesser curvature were obtained in
508 individuals studied in Meshkinshahr.
All the biopsies were received by trained pathology
assistants present in the endoscopy room, who flattened
and oriented the samples by the muscularis mucosa side over
small pieces of filter paper. These samples were immediately
and completely submerged in neutral buffered formalin in
clearly labelled containers. Records of the numbers and sites
of the biopsies were kept using special forms and a coding
system. At the end of the procedure, the data recorded on the
endoscopy and pathology forms were rechecked to ensure
that they were correct. The results of the rapid urease test
were documented on both forms as soon as available. The
pathologist in charge supervised the process of tissue
orientation, fixation, labelling, and recording.
After the endoscopy, the participants were transferred to
the recovery room to be kept under close observation, with
control of vital signs, until they had completely recovered
from sedation. The individuals were then discharged to be
returned to their residential area or taken to the gastro-
enterologist so that further clinical measures or treatments
could be decided upon if any abnormality was noted during
the endoscopy. Appropriate medications were given free of
charge if necessary.
All the tissue samples were transferred to the DDRC
research pathology laboratory in Tehran, processed, and
embedded in paraffin wax blocks, according to standard
protocols. Histological sections were stained by the haema-
toxylin and eosin method.
The histological sections were reviewed by three patholo-
gists with a special interest and experience in GI pathology;
they were informed of the site of each biopsy, but had no
knowledge of the endoscopic and clinical findings. Special
forms were used to record the pathological findings. All the
diagnostic criteria used for our survey were discussed and
sample slides were reviewed by the pathologists before the
study was undertaken to minimise interobserver variations as
much as possible. For the sake of quality assurance, 1/10 of
the samples were randomly checked by another pathologist
in the team, and all the cases with crucial histological
findings were reviewed and discussed in joint sessions.
HISTOLOGICAL CRITERIA AND DEFINITIONS
Gastrit is
Gastritis is defined as the presence of increased numbers of
inflammatory cells of any kind in the lamina propria.
However, a few scattered lymphocytes and rare plasma cells
can normally be seen and tolerated in the normal gastric
antral and cardiac mucosa. Active chronic gastritis is defined
as increased numbers of lymphocytes and plasma cells
(chronic gastritis), accompanied by polymorphonuclear
leucocytes. These polymorphonuclear leucocytes may show
evidence of glandular invasion, similar to the crypt abscesses
seen in inflammatory bowel diseases.14
Mucosal atrophy
Mucosal atrophy is defined as the separation of the mucosal
glands and a decrease in the thickness of mucosa, greater in
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severity than that seen in inflammation of the lamina
propria, and usually associated with an increase in the
stromal matrix.14
Intestinal metaplasia
Intestinal metaplasia (IM) is defined as metaplastic trans-
formation of gastric glandular and surface epithelium
towards intestinal mucosal elements including goblet cells,
absorptive cells, and Paneth cells. The presence of definite
goblet cells is the minimum requirement for the histological
diagnosis of IM.14
Dysplasia
Dysplasia is defined as unequivocal histological evidence of
neoplastic transformation of epithelial cells, including a
constellation of enlargement, hyperchromasia, irregularity,
and pleomorphism of nuclei, nuclear roundening and loss of
polarity, increased mitotic activity with abnormal figures,
decreased cellular mucin content, crowding, and stratifica-
tion of the epithelial cells. These changes should be limited to
the epithelium confined to the intact basement membrane,
with no evidence of invasion to the lamina propria or
surrounding tissue reaction (desmoplasia). The severity
(grade) of dysplasia depends on the intensity and extent of
the involvement of the glandular and surface epithelium of
the gastric mucosa, and is usually classified as low or high
grade.14 15
Reactive atypia
Reactive atypia is defined as cytological and histological
changes similar to low grade dysplasia with coexistence of
active inflammation and/or ulceration. This lesion is also
called indefinite for dysplasia in some classifications.16 To
avoid misclassification we used the term reactive atypia
instead of low grade dysplasia or indefinite for dysplasia.
Adenocarcinoma
Adenocarcinoma is diagnosed when the malignant cells
invade the lamina propria in single cell, glandular, or solid
nest arrangements, usually accompanied by fibrosis of the
surrounding tissue (desmoplasia).14 16
Statistical analysis
The data were expressed as mean (SD), and 95% confidence
intervals were calculated for all point prevalences of the
histological findings. The presence of a variable (for example,
active chronic gastritis) in at least one biopsy sample from
the antral site was considered a positive finding. The absence
of abnormal findings in all specimens from the same biopsy
site was considered as normal. All data were analysed using
SPSS10.0 for Windows.
RESULTS
One thousand and eleven individuals, or 91.5% of those
found eligible, accepted the invitation to participate in our
study: 494 (48.9%) men and 517 (51.1%) women. The
youngest participant was 40 and the oldest 92 years old
(mean age, 53.32; SD, 10.39). Five hundred and seven
(50.1%) participants were residents of the Ardabil and
Meshkinshahr cities and the remaining 505 (49.9%) were
from rural areas. Except for one case of temporary respiratory
depression following Midazolam, which was reversed
promptly, all participants tolerated complete oesophago–
gastro–duodenoscopy uneventfully. Table 1 summarises the
life styles, dietary habits, and body weights of the individuals
investigated.
Endoscopy was reported to be normal in 198 (19.6%) of the
subjects. Table 2 summarises the important endoscopic
findings. Nine hundred and eighty three (97.2%) antral and
816 (80.7%) cardia mucosal biopsies were considered
satisfactory on histopathological examination. The number
of satisfactory tissue samples from the corpus was 505 of 508
biopsies performed (99.4%). The main causes of deferral of
samples for pathological diagnoses were inadequate speci-
mens as a result of small biopsies and lack of proper
orientation of the tissue (2.8% of antral, 0.6% of corpus, and
5.6% of cardia biopsy specimens). One hundred and twelve
(13.7%) of the attempted cardia biopsies showed only
squamous oesophageal mucosa. This is because it is
technically difficult to biopsy this site, resulting in more
sampling errors compared with the corpus and antrum.
The rapid urease test and/or histology were reported to be
positive in 883 of 990 (89.2%) subjects in whom the tests
were performed. Table 3 summarises the histopathological
findings. At the cardiac mucosa, 306 of 816 subjects (37.5%)
had atrophic gastritis, IM, reactive atypia, or glandular
dysplasia. These findings were present in 262 of 505
Table 1 Dietary habits, life style, and nutritional status
Findings N %
Meat consumption (n = 1008)
Less than once a week 229 22.7
1–4 times a week 598 59.3
5–7 times a week 174 17.7
Fresh fruit (n = 1007)
Less than once a week 244 34.5
1–4 times a week 490 48.7
5–7 times a week 196 16.8
Fresh vegetables (n = 1006)
Less than once a week 347 56.3
1–4 times a week 156 31.0
5–7 times a week 64 12.7
Staple diet (n = 1007)
Wheat 847 84.1
Rice 149 14.8
Other 11 1.1
Habits (n = 1011)
Tobacco smoking 302 29.9
Opium smoking 18 1.8
Alcohol consumption 35 3.5
Body mass index (BMI)
Mean (SD), 27.1 (4.7)
BMI (20 25 3.4
20, BMI (25 244 33.4
25, BMI (30 290 39.7
30, BMI (35 121 16.6
BMI .35 51 7.0
Digestive symptoms (.once/month)
Pyrosis 535 52.9
Epigastric pain 443 43.8
Table 2 Endoscopic findings
Finding
Total (n = 1011)
N %
Stomach
Erythema 688 68.1
Erosion 107 10.6
Friability 3 0.3
Nodularity 48 4.7
Polyp 9 0.9
Ulcer gastric 30 3.0
Ulcer (duodenal) 19 1.9
Atrophic mucosa 2 0.2
Raised/thickened area 3 0.3
Normal 198 19.6
Oesophagus
GERD A 280 27.7
GERD B, C, D 71 7.0
GERD, gastro-oesophageal reflux disease.
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(51.9%) of corporal biopsies and in 650 of 983 (66.1%) of the
antral biopsies. Table 4 shows the distribution of atrophy at
different biopsy sites of the gastric mucosa in 508 cases from
Meshkinshahr.
Statistical analysis (table 5) revealed no significant
correlation between demographic factors and precancerous
lesions, but it did show a protective effect of meat (p for trend
, 0.05) and fresh vegetable (p for trend , 0.01) consump-
tion for antral IM only, but not for corpus or cardia IM.
DISCUSSION
Gastric carcinogenesis involves a slow but continuous
stepwise evolution from superficial gastritis, glandular
atrophy to metaplasia, dysplasia and, finally, to adenocarci-
noma.15 17 This slow process of carcinogenesis, which may
well extend over decades, provides an excellent opportunity
for early detection and intervention to prevent further
progression or regression of the carcinogenic process. This
is especially true because H pylori (which is readily treatable)
is known to be the main aetiological agent and initiating
carcinogen. Uemura et al have already shown that in Japan all
patients who developed gastric cancer were infected with
H pylori.11 This finding may mean that other aetiological
factors alone are not sufficient to induce gastric cancer and
that H pylori plays a pivotal role in the process of gastric
carcinogenesis.
In Ardabil, which has the highest mortality from gastric
cancer in Iran, we carried out a cross sectional endoscopic
screening study to look for precancerous gastric lesions, with
the aim of designing an appropriate preventive and inter-
ventional strategy to decrease the mortality from this fatal
cancer. We have identified a range of precancerous lesions,
the most notable of which were chronic active H pylori
associated gastritis in at least one of the biopsy sites in more
than 90% of subjects. Atrophic gastritis, reactive atypia, IM,
and dysplasia were seen in at least one biopsy site in 71.8% of
subjects. The rate of IM and dysplasia was not as high as that
reported from China18 19 or Columbia.20 The reasons for this
discrepancy may be (1) the age standardised rate for gastric
cancer in Ardabile is 50, which is lower than in Linqu in
northeast China or the Narin,o region of Colombia, where it
is around 70 and (2) to prevent misclassification, we
classified the less advanced lesions of low grade dysplasia
and indefinite for dysplasia as reactive atypia, rather than
dysplasia. We used only the urease test and histology
(haematoxylin and eosin staining) to look for H pylori and
in 89.2% of the subjects, at least one of the tests was positive.
If we had also used serology or the breath test, or a more
specific stain, such as Giemsa, the rate of H pylori positivity
would probably have been higher, perhaps approaching 95–
98%. It seems that in Ardabil almost all people 40 year old
and above had H pylori associated chronic gastritis involving
the antrum, corpus, and cardia, which was more severe in the
antrum and corpus and became less prominent in the cardia.
In contrast to the high risk populations of Japan, China, and
Columbia, where more than 60% of gastric cancers are
located in the antrum, in Ardabil more than 60% of gastric
cancers are located in the proximal stomach, mainly in the
cardia.6 21
Adenocarcinoma of the gastric cardia has a different
biological behaviour, with a worse outcome and a shorter
survival compared with its distal counterpart. Although
H pylori infection is well established as the main risk factor
for non-cardia gastric cancer, studies from the USA and
Europe have provided some evidence that cagA+ strains may
have an inverse relation with gastric cardia and oesophageal
adenocarcinomas,22–25 but reports from high risk regions26 27 of
Asia emphasise that these strains may also be a risk factor for
proximal gastric cancer. It remains to be determined what
proportion of proximal gastric cancer in these high risk
regions of the world is the result of non-H pylori related
factors.
‘‘The adoption of a Western type life style and exposure to
some additional, unknown environmental carcinogens
may be the reason for the increasing rate of cardia
cancer in Ardabil’’
The diverging trend in the incidence of gastric cancer in
these two subsites in Western countries points to a different
aetiology. Exposure to environmental carcinogens (such as
nitric oxide),28 overeating, obesity,29 and resultant hyperacid-
ity in the cardia region,30 which are the consequences of life
style changes, seem to be more important in the pathogenesis
of cardia gastric cancer.
During the past two decades, the Ardabili residents, who
were all infected with H pylori during childhood,31 have
Table 3 Histopathological findings of gastric cardia, corpus, and antral biopsies
Histological findings
Antrum (983) Corpus (505) Cardia (816)
N % (95% CI) N % (95% CI) N % (95% CI)
Normal 30 3.1 (2.0 to 4.2) 37 7.3 (5.0 to 9.6) 111 13.6 (11.2 to 16.0)
Chronic gastritis 338 34.4 (31.4 to 37.4) 271 53.7 (49.3 to 58.1) 224 27.5 (24.4 to 30.6)
Active chronic gastritis 765 77.8 (75.2 to 80.4) 303 60.0 (55.7 to 64.3) 472 57.8 (54.4 to 61.2)
H pylori infection 818 83.2 (80.9 to 85.5) 328 65.0 (60.8 to 69.2) 492 60.3 (56.9 to 63.7)
Reactive atypia 431 43.8 (40.7 to 46.9) 109 21.6 (18.0 to 25.2) 187 22.9 (21.3 to 24.5)
Atrophic changes 444 45.2 (42.1 to 48.3) 232 46.9 (42.6 to 51.2) 179 21.9 (20.5 to 23.3)
Intestinal metaplasia 128 13.0 (10.9 to 15.1) 42 8.3 (5.9 to 10.7) 31 3.8 (2.5 to 5.1)
Glandular dysplasia 2 0.20 (20.07 to 0.47) 1 0.2 (0.01 to 0.39) 2 0.25 (20.09 to 0.58)
Adenocarcinoma 3 0.31 (20.03 to 0.65) 0 0 1 0.12 (20.11 to 0.35)
Antrum: positive finding in at least one of Bx1, Bx2, or Bx3; corpus: positive finding in at least one of Bx4 or Bx5.
CI, confidence interval.
Table 4 Distribution of atrophy in 508 subjects from
Meshkinshahr with corpus biopsies
Site N (%) Subsite N (%)
Cardia (n = 492) 142 Cardia+antrum+corpus 112 (22.0%)
(28.9%) Cardia+antrum 13 (2.6%)
Cardia+corpus 10 (2.0%)
Cardia only 7 (1.4%)
Corpus (n = 505) 223 Corpus+antrum+cardia 112 (22.0%)
(45.9%) Corpus+antrum 86 (17.2%)
Corpus+cardia 10 (2.0%)
Corpus only 15 (3.0%)
Antrum (n = 508) 270 Antrum+corpus+cardia 112 (22.0%)
(53.1%) Antrum+corpus 86 (17.2%)
Antrum+cardia 13 (2.6%)
Antrum only 59 (11.6%)
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gradually adopted a Western pattern of life style. More than
60% are overweight, with a body mass index of more than 25
(table 1), and most have access to adequate numbers of
calories, mainly from bread, fat, and meat, whereas 35% and
24% still do not eat enough fresh vegetables and fruit,
respectively (table 1). More than 50% have at least one
episode of pyrosis each week and 35% of them were found to
have evidence of at least mild erosive oesophagitis.
It seems plausible that although H pylori infection probably
plays a pivotal role in the initiation of the carcinogenic
process in the antrum, the adoption of a Western type life
style and exposure to some additional, unknown environ-
mental carcinogens may be the reason for the increasing rate
of cardia cancer in Ardabil. Although we found that fresh
vegetable and meat consumption had a protective effect
against antral IM (table 5), our study failed to demonstrate a
significant correlation with other dietary or demographic
factors because of the small numbers of subjects with cancer
and precancerous lesions. Further studies specifically
designed to look for these correlations should be per-
formed, such as case control studies using food frequency
questionnaires.
The interaction between H pylori induced carcinogenesis
and hyperacidity induced hyperproliferation of the proximal
gastric mucosa is also an interesting area of investigation. It
is probable that H pylori infection does not play a permissive
role, as it most likely does in non-cardia gastric cancer, but it
may be considered an additive risk, especially in high risk
areas of the world, where both H pylori infection and gastric
cancer are more common.
Previous studies have indicated that screening for the
detection and treatment of H pylori infection to prevent
gastric cancer is potentially cost effective if at least 30% of
cancers attributable to H pylori can be prevented.32 The results
of reported interventional trails from Japan and Columbia are
very encouraging, and favour the notion that the eradication
of H pylori infection is a promising option for the prevention
of gastric cancer, at least in high risk regions of the world;
therefore, non-cardia gastric cancer may in the future be
considered as a largely preventable disease.11 13
The role of dietary nitrate derived nitric oxide in the
aetiology of gastro–oesophageal junction cancer in Scotland22
has recently been related to the excess use of nitrogenous
fertilisers and associated increased dietary nitrate exposure.
In Ardabil, like other parts of Iran, there has been more than
a 15 fold increase in the use of chemical nitrogenous
fertilisers. Ardabil Province has also some geographical
similarities with other high incidence areas of gastric cancer,
the so called volcanic countries, such as Costa Rica, Chile,
and Japan, by being located near a silent volcano named
Sabalan. Therefore, a similar environmental factor, such as
nitrous volcanic soils, may contribute to the higher incidence
of upper GI cancer in this area.33
Further epidemiological studies need to be performed to
evaluate the role of dietary nitrates and other carcinogens,
which could be secreted in saliva and accumulate in the
cardia, in the pathogenesis of gastric cardia cancer.
Epidemiological studies should also be performed in
different ethnic subgroups of northern, central, and south
Iran with different prevalence rate for tumours looking at all
four major types of upper GI cancers, including cancers of the
distal stomach and gastric cardia, in addition to adenocarci-
noma and squamous cell carcinoma of the oesophagus.
Our study indicates that, in Ardabile, adequate planning
and resources may make such studies feasible and economic.
Our findings are relevant to populations with very high
gastric cancer rates and a very high prevalence of H pylori
infection. They may be less relevant to populations with a low
gastric cancer risk, with a low prevalence of gastric cancer.
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